In 2025, the Strengthening Maternal Platforms for Vaccines and Preparedness (StaMP) RSV study, supported by US Centers for Disease Control and the Task Force for Global Health, assessed knowledge, attitudes, and practices (KAP) related to RSV prevention among pregnant women (PW) and healthcare workers (HCWs) in direct contact with pregnant women in Bangladesh, Guatemala, Jordan, and Zambia. The study explored current awareness of RSV, any concerns about safety and/or effectiveness of the prevention products, and other potential barriers to and facilitators of recommendation or uptake of the products.
This package provides the study tools and resources to easily guide a study of healthcare workers’ and pregnant women’s knowledge, attitudes, and intended practices related to RSV and the preventive products of maternal vaccine and infant monoclonal antibody, with the purpose of informing policy decisions and planning for national recommendations to introduce the prevention products.
Cover and Table of contents
Protocol
Survey tools
| Titre | Auteur | Année | Type | Langue |
|---|
| RSV KAP 2.0 HCW Questionnaire | Joseph Bresee, Cara Tupps, Ann Moen | 2026 | Datasheet | Anglais |
| RSV KAP 2.0 Pregnant Women Survey Tool | Joseph Bresee, Cara Tupps, Ann Moen | 2026 | Tool | Anglais |
| RSV KAP 2.0 PW Electronic Questionnaire | Joseph Bresee, Cara Tupps, Ann Moen | 2026 | Datasheet | Anglais |
| RSV KAP HCW Survey Tool | Joseph Bresee, Cara Tupps, Ann Moen | 2026 | Tool | Anglais |
| Tips for Enumerators RSV KAP 2.0 | Joseph Bresee, Cara Tupps, Ann Moen | 2026 | Tool | Anglais |
Sampling support
Qualitative Focus Groups or Interview Guides
